BioRestorative Therapies (NASDAQ:BRTX) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

BioRestorative Therapies (NASDAQ:BRTX) released its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.07, Zacks reports. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. The firm had revenue of $0.50 million for the quarter, compared to analysts’ expectations of $0.48 million.

BioRestorative Therapies Stock Performance

Shares of NASDAQ BRTX opened at $1.81 on Friday. The company has a market cap of $12.53 million, a P/E ratio of -1.18 and a beta of 64.37. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55. The firm’s fifty day moving average is $1.97 and its two-hundred day moving average is $1.72.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.